AstraZeneca

Open: 72.55 Close: 72.52 Change: -0.03

The stock market through the eyes of an AI: AstraZeneca Stock.

The game is changing. There is a new strategy to evaluate AstraZeneca fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, cancer, share, Cancer, Drug, year, Astra, and the …

Concept Map

Semantic Network

Stock Summary

AstraZeneca PLC focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa,.

Today's Summary

AstraZeneca/Mercks Cancer Drug Drug Drug drug Drug Drug Combo Shows Positive Results In Endometrial Cancer. Company is now looking for “modest profitability” on its covid-19 vaccines.

Today's News

AstraZeneca has decided to make money from the pandemic after all. Company is now looking for “modest profitability” on its covid-19 vaccines. AstraZeneca/Mercks Cancer Drug Drug Combo Shows Positive Results In Endometrial Cancer. 1Q Revenue Consensus Was $10.60B. AstraZeneca has been a leading advocate for sustainability in the region. At COP27 last year, Astra Zeneca Egypt announced several programs to accelerate the decarbonisation of healthcare and the establishment of green hospitals in the country. Astra has also invested in decarbonising its supply chain, by shifting supply routes. Merck and AstraZeneca enter strategic oncology collaboration. Collaboration will involve co-development and co-commercialisation of Lynparza (olaparib) oral poly ADP ribose polymerase (PARP) inhibitor for multiple cancer types. AstraZeneca hires LSEG CFO Anna Manz as non-executive director from September 1. Imfinzi plus Lynparza effective for endometrial cancer, company says. AstraZeneca aims to create an open research environment that connects our expertise and technologies with the innovative ideas of collaborators like UCL and MRC LMB. In this webinar, our speakers will share the background of AstraZecas efforts. AstraZeneca and Pfizer remain in the top positions this year for invention and innovation. Astrazeneca plc (azn) statistics & valuation metrics - stock analysis. AstraZeneca has 3.10 billion shares outstanding. Average price target is $79.00, which is 8.94% higher. AstraZeneca has several key R&D, manufacturing and commercial locations across the United States. AstraZenecas IMFINZI-based treatment before and after surgery reduced the risk of disease recurrence, progression events or death by 32% in resectable non-small cell lung cancer in the AEGEAN Phase III trial. TEZSPIRE® (tezepelumab-ekko) approved in the US for self-administration. AstraZeneca is responding to the COVID-19 (novel coronavirus) outbreak, consistent with our values to follow the science. AstraZeneca shares its thoughts on World Heart Summit 2023.

Stock Profile

"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom."

Keywords

This document will help you to evaluate AstraZeneca without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AstraZeneca are: AstraZeneca, cancer, share, Cancer, Drug, year, Astra, and the most common words in the summary are: astrazeneca, news, cancer, patient, business, astrazenecas, trial, . One of the sentences in the summary was: Company is now looking for “modest profitability” on its covid-19 vaccines.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #astrazeneca #news #cancer #patient #business #astrazenecas #trial.